Loading...

Haleon plc

HLNCF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$4.95
$0.00(0.00%)

Haleon plc (HLNCF) Stock Overview

Explore Haleon plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 71.5/100

Key Financials

Market Cap44.9B
P/E Ratio23.46
EPS (TTM)$0.21
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Week$5.65
1 Month$5.54
3 Months$5.59
1 Year Target$5.62

HLNCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haleon plc (HLNCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.46 and a market capitalization of 44.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;